EyePoint Pharmaceuticals, Inc. - COM NEW (EYPT)

Historical Portfolio Holders from Q4 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
58.4M
Holdings value Q2 2024
$508M
Value change Q2 2024
+$32.4M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
147
Number of buys Q2 2024
32
Number of sells Q2 2024
-10
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 58.4M $508M +$32.4M $8.70 150
2024 Q1 4.79M $98.9M -$39.5M $20.67 26
2023 Q4 49.6M $1.15B +$396M $23.11 138
2023 Q3 33.7M $269M +$16.7M $7.99 97
2023 Q2 31.6M $275M +$22.9M $8.70 82
2023 Q1 29.1M $85.6M -$1.21M $2.94 66
2022 Q4 29.4M $103M -$6.52M $3.50 71
2022 Q3 29.2M $231M +$33.4K $7.91 79
2022 Q2 29.2M $230M +$661K $7.87 75
2022 Q1 30.1M $366M +$7.72M $12.15 74
2021 Q4 29.8M $365M +$95.1M $12.24 85
2021 Q3 22.1M $230M +$15M $10.42 62
2021 Q2 20.7M $186M +$7.94M $8.99 60
2021 Q1 19.6M $200M +$124M $10.16 58
2020 Q4 7.7M $50.7M +$50.7M $6.58 33